Are you interested in presenting a Thyroid paper for the ATA’s new trainee and early career journal club? We have identified three high impact papers published in the Thyroid journal and are looking for individuals that would be willing to help us present the papers during a future Career Connections Meetup. We will be pairing 2 trainee presenters and an expert ATA member who will serve as a moderator. The moderator will provide insight into how this paper fits into the current landscape and field, either clinically or scientifically.

If you are a trainee or early career professional and interested in presenting one of the papers listed below please complete this form.

Questions? Email trainees@thyroid.org

Papers:

Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from beta-Amyloid Toxicity:

A novel form of thyroid hormone (TH) signaling is represented by 3-iodothyronamine, an endogenous TH derivative that interacts with specific molecular targets, including the trace amine-associated receptor 1 (T1AM), and induces pro-learning and anti-amnestic effects in mice. This represents a novel signaling pathway linked to memory and loss of memory. Dysregulation of TH signaling has long been hypothesized to play a role in Alzheimer’s disease. In this study, the authors explored the neuroprotective role of T₁AM in beta amyloid (Aβ)-induced synaptic and behavioral impairment, focusing on a specific area within the brain that is affected early in Alzheimer’s Disease pathology and progression.

https://www.liebertpub.com/doi/10.1089/thy.2019.0255

Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases:

This study the largest study to date to investigate and link the clinical, genetic and histological characteristics if Anaplastic thyroid cancer. The study is retrospective evaluating patients from two tertiary centers.

https://www.liebertpub.com/doi/10.1089/thy.2020.0086

Comprehensive Immune Profiling of Medullary Thyroid Cancer:

This study is the first one to comprehensively investigate and define the immune milieu, immune-suppressive molecules and tumor antigens in MTC patients. 46 patients were evaluated in the study, finding robust infiltration of CD8+ T cells and macrophages in these tumors and metastatic lesions. This study identifies and describes how immune modulatory therapies may be a novel approach for treatment of MTC including potential for developing adoptive T cell therapies to treat MTC.

https://www.liebertpub.com/doi/10.1089/thy.2019.0604

The post Trainee Journal Club Volunteer Form appeared first on American Thyroid Association.

The post Research Grant for Study of Resistance to Precision Medication for Medullary Thyroid Cancer Is Awarded to Brendan Frett, PhD, by the American Thyroid Association appeared first on American Thyroid Association.

The post Research Grant to Study Common Resistance to Papillary Thyroid Cancer Treatment Is Awarded to Ann-Kathrin Eisfeld, MD, by the American Thyroid Association appeared first on American Thyroid Association.

Renowned experts in thyroid function and biology, diagnosis and management of thyroid disease, and novel therapies for treating thyroid cancer will gather at the 15^th International Thyroid Congress (ITC) to present, discuss, and debate the latest advances in thyroidology. The ITC will take place October 18-23, 2015 at the Walt Disney World Swan and Dolphin Resort in Lake Buena Vista, Florida. Held every five years, the ITC is a collaborative meeting of the four world thyroid associations held every fifth year: ATA (American Thyroid Association), Asia-Oceania Thyroid Association (AOTA), European Thyroid Association (ETA), and Latin American Thyroid Society (LATS).

Two special lectures highlight the fifth day of programming at ITC, on Thursday, October 22. In the morning, Janete Maria Cerutti will deliver the Latin American Thyroid Association Prize Lecture, with an introduction by Rui Maciel. Delivering the European Thyroid Association Prize Lecture in the afternoon will be V. Krishna Chatterjee. On Friday, October 23, Sally E. Carty, to be introduced by Electron Kebebew, will deliver a Plenary Lecture entitled "Progress in the Surgical Management of Neoplasia and Hyperthyroidism.

The ITC Program Committee has scheduled a series of provocative Discussions/Debates on Thursday, Day Five of the Congress, one focusing on clinical topics and the other areas related to basic and translational research. The Clinical Discussions/Debates will explore a range of controversial topics: “Pharmacological and Destructive Therapies for Benign Nodules” with Laszlo Hegedus and Jeong Hyun Lee; “Controversies in the Treatment of Graves’ Disease in Children” with Scott Rivkees and Juliane Leger; “Optimal Ultrasound and Scintigraphy for Thyroid Cancer” with Jin Young Kwak and Markus Luster; “Minimizing Birth Defects after Use of Anti-Thyroid Drugs in Pregnancy” with Jorge H. Mestman and Bijay Vaidya; “Technique and Extent of Lymph Node Dissection for Thyroid Cancer” with Zvonimir Luka Milas and Ashok Shaha.     

Thursday’s Basic/Translational Discussions/Debates will feature the following topics and participants: "New Molecular Drivers in Thyroid Cancer" with Mingzhao Xing and Minho Shong; "Negative Regulation of Target Genes by TH" with Fredrick Wondisford; "Genetics of Thyroid Development" with Roberto di Lauro; "Selenium and the Thyroid: International Studies and Experiences" with Bingyin Shi and Kristian Winther; and "Key Steps in Thyroglobulin Iodination and Thyroid Hormonogenesis" with Juan Pablo Nicola and Peter Arvan.

Symposiums on an array of timely topics chaired by international experts and featuring leading researchers and clinicians invited to share their knowledge and experiences will take place throughout the day on Thursday. Beginning with the Early Riser Symposium, Chairs Josef Koehrle and Manisha Shah have organized a session entitled ”Update on Differentiated Thyroid Cancer–Molecular Mechanisms and Treatment" featuring Haixia Guan speaking on Altered Cell Metabolism in Thyroid Cancer; Laura Ward on Targeting the Thyroid CAncer Microenvironment; Marcia Brose on Single or Combination Targeted Therapy?; and Matthew Ringle on "Comparison of Latest Guidelines on Differentiated Thyroid Cancer."

Continuing on Thursday morning at ITC will be four symposia taking place in parallel sessions. The Case-Based Symposium entitled ”International Perspectives on Treatment of Graves’ Disease" led by Moderator David S. Cooper will feature Won Bae Kim from AOTA, Ana Luisa Maia from LATS, Helena Filipsson Nystrom from ETA, and M. Regina Castro from ATA.

The symposium “Target Tissue Responses to Thyroid Hormone, “ organized by Chairs Carmen Pazos de Moura and Donald St. Germain, will feature presentations by Tania Ortiga on the Hypothalamic Pituitary Axis; Anthony Hollenberg  on the Role of Co-Factors in TR and Tissue-Selective Thyroid Hormone Action; and Cecilia H.A. Gouveia on the Skeleton.

Chairs Gregory Brent and Noriyuki Koibuchi will lead the symposium “Thyroid Hormone Axis–A Target for Endocrine Disrupting Compounds (EDC),” with presenters Josef Köhrle speaking on Novel Non-Radioactive Screening Assays for Testing EDC Action; Barbara Anne Demeneix on Thyroid Disrupting Effects of Chemicals Found in Human Amniotic Fluid; and Angela Leung on Perchlorate and the Thyroid Axis in Human Pregnancy and Lactation.

In the symposium called "Emerging Approaches to Papillary Microcarcinoma Management" Chairs Leonidas Duntas and Akira Miyauchi present speakers Anna M. Sawka on the topic of Epidemiology; Yasuhiro Ito on Active Surveillance; and Fabian Pitoia on Risk Factors for Persistent and Recurrent Disease.

ITC’s Thursday afternoon program will feature an additional set of four symposia on various highly relevant topics including “IgG4-Related Sclerosing Disease and the Thyroid” with Chairs Marius Stan and Mitsuyasu Itoh, in which Arezou Khosroshahi will give a Clinical Overview of IgG4-Related Sclerosing Disease; Kennichi Kakudo will present IgG4 in Thyroiditis in Hashimoto’s and Reidel’s; and James Garrity will speak on Graves’ Orbitopathy and IgG4 Ocular Disease.

Exploring the ”Non-Genomic Actions of TH" will be session Chairs Riccardo Zucchi and Claudia Pellizas, with an Overview to be presented by Karine Gauthier; a talk on Nuclear Receptor Mediated Non-Genomic Actions by Lars C. Moeller; and a presentation on "Membrane Reception Mediated Non-Genomic Actions by Maria Tereza Nunes.

The Thursday afternoon symposia at ITC will also include a session entitled “Longevity in Thyroid Status.” Joining Chairs Patricia de Fatima dos Santos Teixeira and Anne Cappola are presenters Denise Zwanziger discussing Animal Studies on Thyroid and Aging; Bjorn Olav Asvold speaking on Survival Data from Epidemiologic Studies; and Laura Boucai focusing on TSH Thresholds for Therapy. The symposium “Novel Therapies for Thyroid Autoimmune Diseases” led by Chairs Takashi Akamizu and Terry F. Davies will include presentations on Small Molecule TSHR Antagonists by Marvin C. Gershengorn; Blocking Antigen Presentation by Yaron Tomer; and Future Therapeutic Targets in Graves’ Orbitopathy by Wilmar M. Wiersinga.

The ITC Program Organizing Committee (POC) has invited renowned international thyroid experts for every symposium and discussion/debate. The POC has designed this ITC to highlight and involve young investigators from around the world.  The American Thyroid Association (ATA) will continue to promote the E. Chester Ridgway Trainee Conference with a unique and focused track for trainees; participation includes accommodations and complimentary registration for a limited number of applicants who are first authors on accepted abstracts.  The four international thyroid associations combine their efforts to contribute to this one of a kind, state-of-the-science experience! Don’t miss this “top of the mark” collegial event.

Hosted by the ATA, the ITC will bring together the international community of thyroid researchers and clinicians to present and discuss the latest advances and controversies in thyroidology.  The ATA and its annual meetings are well known and well regarded by all those devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health.

###

The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis, and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,700 members from 43 countries around the world. Celebrating its 92^nd anniversary, the ATA delivers its mission — of being devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health — through several key endeavors: the publication of highly regarded professional journals, Thyroid, Clinical Thyroidology, and VideoEndocrinology; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease and thyroid cancer. The ATA promotes thyroid awareness and information through its online Clinical Thyroidology for the Public (distributed free of charge to over 11,000 patients and public subscribers) and extensive, authoritative explanations of thyroid disease and thyroid cancer in both English and Spanish. The ATA website serves as the clinical resource for patients and the public who look for reliable information on the Internet.  Every fifth year, the American Thyroid Association joins with the Latin American Thyroid Society, the European Thyroid Association, and the Asia and Oceania Thyroid Association to co-sponsor the International Thyroid Congress (ITC).  This year the ITC is hosted by the American Thyroid Association at the Walt Disney World Swan and Dolphin Resort.  More information about the 15^th ITC can be found at http://www.thyroid.org/itc2015/.

The post 15th International Thyroid Congress to Highlight Latest Advances in Research and Clinical Management of Thyroid Disease appeared first on American Thyroid Association.

Featuring symposiums, panel discussions and debates, and Plenary Lectures led by renowned endocrinology specialists, surgeons, and other healthcare professionals and experts in thyroidology from around the world, the 15^th International Thyroid Congress (ITC) will take place October 18-23, 2015 at the Walt Disney World Swan and Dolphin Resort in Lake Buena Vista, Florida. The ITC, held every five years, is a collaborative meeting of the four world thyroid associations: ATA (American Thyroid Association), Asia-Oceania Thyroid Association (AOTA), European Thyroid Association (ETA), and Latin American Thyroid Society (LATS).

On Wednesday, October 21, Day Four of ITC will feature two Plenary Lectures: a morning presentation by Shigenobu Nagataki entitled “Radiation and the Thyroid: From Hiroshima/Nagasaki, Chernobyl to Fukushima,” with an introduction by Yoshiharu Murata; and an afternoon lecture by Samuel Refetoff, introduced by Roy Weiss, on Congenital Thyroid Disorders.

A series of lively Discussions/Debates on Wednesday will focus on either clinical topics or basic/translational areas of research. Announced topics and participants for the Clinical Discussions/Debates include: “Core and Fine Needle Biopsy: Pros and Cons” with Jung Hwan Baek and Teresa Cristina Santos Cavalcanti; “Technical and Clinical Pitfalls in Thyroglobulin Assays” with Carole Spencer and Cosimo Durante; “Drug-Induced Thyroid Dysfunction” with Leonidas Duntas and Sahzene Yavuz; “Remnant Ablation in Thyroid Cancer—Selective vs. Routine” with Sebastiano  Filetti and Bryan McIver; and “Long-Term Consequences of Subclinical Hyperthyroidism” with Cristian Selmer and Bernadette Biondi.

Wednesday’s Basic/Translational Discussions/Debates will feature the following topics and participants: “Thyroid Function and Cognition Across the Life Span” with Fabio Monzani and Jacoba Bongers-Schokking; “Central Control of TH Availability” with Balázs Gereben; “Thyronamines and Other TH Metabolites” with Carolin S. Höfig and Pieter De Lange; “Central and Peripheral Control of Energy Expenditure by TH” with Eric Fliers”; and “Molecular Testing in Thyroid Nodules” with Ralf Paschke and Janete M. Cerutti.

Symposiums on a range of hot topics chaired by world experts in their fields and featuring leading researchers and clinicians invited to share their knowledge and experiences will take place throughout the day on Wednesday. Beginning with the Early Riser Symposium, Chairs Ling Zhang and Claudio Cernea have organized a session on “New Developments in Thyroid Surgery” featuring Kerstin Lorenz speaking on Nerve Monitoring; Woong Youn Chung on Remote Access Thyroid Surgery; and Saba Balasubramanian on Prevention and Treatment of Post-Surgical Hypoparathyroidism.

Morning symposia on Wednesday at ITC will include four parallel sessions. In the symposium called “Lessons from Animal Models of Thyroid Autoimmunity” Chairs Sun Wook Kim and Marian Ludgate will highlight the work of presenters J. Paul Banga on Graves’ Orbitopathy; Yuji Nagayama on Graves’ Disease; and Basil Rapoport on Hashimoto’s Thyroiditis.

“Novel Actions of Thyroid Hormone on Metabolism,” led by Chairs Peter Kopp and Anja van Gucht, will include the following topics: TH Action in Control of Cardiovascular Function, presented by Jens Mittag; TH Action Control of Hepatic Cholesterol and Lipid Metabolism, by Paul Yen; and Deiodinase Mediated TH Action in the Liver, by Tatiana L. Fonseca.

The symposium entitled “Emerging Strategies in Pregnancy Screening for Thyroid Dysfunction,“ organized by Chairs Marcos Abalovich and Peter Laurberg, will feature presentations by Brian M. Casey on the NIH Pregnancy Study; Weiping Teng on the Chinese Screening Study (SHEP); and John H. Lazarus on Similarities and Differences in International Recommendations.

Chairs Pilar Santisteban and Tesuo Kondo will lead the symposium on “Genetics and Biomarkers of Thyroid Cancer,” with presenters Gisah A. Carvalho speaking on Is TSH a Risk Factor for Thyroid Cancer?; Carine Maenhaut on Molecular Profiling of Thyroid Neoplasms; and Antonio Di Cristofano on Genetic Models of Thyroid Cancer.

ITC’s Wednesday afternoon program will feature another set of four fascinating symposia including “Advances in the Treatment of Graves’ Orbitopathy” with Chairs Yushu Li and Wilmar Wiersinga and presentations by Claudio Marcocci on Selenium in Mild Graves’ Orbitopathy: What’s New?; George J. Kahaly on Optimal Use of Intravenous Steroids; and Peter Dolman on Orbital Surgery.

Exploring “The Role of TH in Stem Cell Renewal” will be session Chairs Arturo Hernandez and Heike Bieberman, with focused presentations on Intenstinal Epithelium by Michelina Plateroti; Neural Stem Cell Fate by Sylvie Remaud; Muscle Satellite Cells by Monica Dentice; and Pre-Adipocytes by Gregory A. Brent.

The Wednesday afternoon symposia at ITC will include a session entitled “Iodine Deficiency Throughout Life.” Joining Chairs Sun Lee and Elizabeth Pearce are presenters Zhongyan Shan discussing Pregnancy; Maria Andersson speaking on Childhood; and Eduardo Pretell focusing on Adults. The symposium “Controversies in Thyroid Surgery” led by Chairs Quan-yang Duh and Amy Chen targets two key areas: Routine or Selective Central Neck Dissection for Low-Risk PTC?, to be discussed by Hang-Seok Chang and Lisa Orloff; and Advantages and Disadvantages of Minimally Invasive Thyroidectomy, to be examined by Paolo Miccoli and Henning Dralle.

The ITC Program Organizing Committee (POC) has invited renowned international thyroid experts for every symposium and discussion/debate. The POC has designed this ITC to highlight and involve young investigators from around the world.  The American Thyroid Association (ATA) will continue to promote the E. Chester Ridgway Trainee Conference with a unique and focused track for trainees; participation includes accommodations and complimentary registration for a limited number of applicants who are first authors on accepted abstracts.  The four international thyroid associations combine their efforts to contribute to this one of a kind, state-of-the-science experience! Don’t miss this “top of the mark” collegial event.

Hosted by the ATA, the ITC will bring together the international community of thyroid researchers and clinicians to present and discuss the latest advances and controversies in thyroidology.  The ATA and its annual meetings are well known and well regarded by all those devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health.

###

The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis, and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,700 members from 43 countries around the world. Celebrating its 92^nd anniversary, the ATA delivers its mission — of being devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health — through several key endeavors: the publication of highly regarded professional journals, Thyroid, Clinical Thyroidology, and VideoEndocrinology; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease and thyroid cancer. The ATA promotes thyroid awareness and information through its online Clinical Thyroidology for the Public (distributed free of charge to over 11,000 patients and public subscribers) and extensive, authoritative explanations of thyroid disease and thyroid cancer in both English and Spanish. The ATA website serves as the clinical resource for patients and the public who look for reliable information on the Internet.  Every fifth year, the American Thyroid Association joins with the Latin American Thyroid Society, the European Thyroid Association, and the Asia and Oceania Thyroid Association to co-sponsor the International Thyroid Congress (ITC).  This year the ITC is hosted by the American Thyroid Association at the Walt Disney World Swan and Dolphin Resort.  More information about the 15^th ITC can be found at http://www.thyroid.org/itc2015/.

The post World Renowned Experts to Participate in Symposia, Discussions and Debates at 15th International Thyroid Congress appeared first on American Thyroid Association.

Renowned experts in thyroid function and biology, diagnosis and management of thyroid disease, and novel therapies for treating thyroid cancer will gather at the 15^th International Thyroid Congress (ITC) to present, discuss, and debate the latest advances in thyroidology. The ITC will take place October 18-23, 2015 at the Walt Disney World Swan and Dolphin Resort in Lake Buena Vista, Florida. Held every five years, the ITC is a collaborative meeting of the four world thyroid associations held every fifth year: ATA (American Thyroid Association), Asia-Oceania Thyroid Association (AOTA), European Thyroid Association (ETA), and Latin American Thyroid Society (LATS).

Two special lectures highlight the third day of programming at ITC, on Tuesday, October 20. In the morning, Luigi Bartalena will deliver the Plenary Lecture entitled “Choice of Therapy for Graves’ Hyperthyroidism,” with an introduction by Furio Pacini. Delivering the AOTA Prize Lecture, “Toward Best Management of Thyroid Cancer” in the afternoon will be Akira Miyauchi, introduced by Takashi Akamizu.

The Women in Thyroidology Networking Meeting, with the theme “The Mentor Within” and led by Ofelia Olivero will take place Tuesday afternoon.

The ITC Program Committee has scheduled a series of provocative Discussions/Debates on Tuesday, Day Three of the Congress, one focusing on clinical topics and the other areas related to basic and translational research. The Clinical Discussions/Debates will explore a range of controversial topics: “How Reliable are Free Thyroid Hormone Assays?” with Stefan K.G. Grebe and Steve Soldin; “Rituximab Therapy for Graves’ Orbitopathy” with Mario Salvi and Marius N. Stan; “Maternal Isolated Hypothyroxinemia: What Do We Know and What Don’t We Know?” with Marco Medici and Chrysoula Dosiou; “Is it Possible to Improve Outcomes in Congenital Hypothyroidism?” with Stephen H. LaFranchi and Tone Torresani; “Emerging Concepts In The Management of Recurrent Thyroid Cancer” with Kenneth Burman and Enrico Papini.

Tuesday’s Basic/Translational Discussions/Debates will feature the following topics and participants: “Clinical and Basic Aspects of Bone Turnover by Thyroid Hormone” with John G. Logan and Bente Langdahl; “Roles of TSH from Pars Tuberalis and Pars Distalis” with Takashi Yoshimura; “Thyroid Function and Metabolic Syndrome” with Gabriela Brenta and Jiajun Zhao; “Deiodinases and Cancer” with Stephen A. Huang and Domenico Salvatore; and “TSHR Structure” with Jane Sanders and Ricardo Núñez Miguel.

Symposiums on an array of timely topics chaired by international experts and featuring leading researchers and clinicians invited to share their knowledge and experiences will take place throughout the day on Tuesday. Beginning with the Early Riser Symposium, Chairs Rossana Corbo and Andrew J. Bauer have organized a session entitled ” Differences Between Pediatric and Adult Differentiated Thyroid Cancer” featuring Sylvia L. Asa speaking on Thyroid Cancer Phenotypes; Cristoph Reiners on Approach to Radioiodine Treatment; Fernanda Vaisman on Thyroid Cancer Outcome; and Steven G. Waguespack on ” Thyroid Cancer Guidelines.”

Tuesday morning’s program continues with four parallel Oral Abstracts sessions. Two sessions will focus on Clinical topics, including “Thyroid Cancer Therapy and Outcomes” led by Chairs Duncan Topliss and Sara Ahmadi, and “Autoimmunity and Pregnancy” with Chairs Yasumasa Iwasaki and Maria Cabanillas. The Basic Oral Abstract sessions are entitled “Thyroid Signaling Metabolism and Action,” led by Chairs Sheue-yann Cheng and Juan Nicola, and “Thyroid Cancer Genetics/Genomics, with Chairs Rafaelle Ciampi and Rebecca Schweppe.

ITC’s Tuesday afternoon program will feature a set of four symposia on various highly relevant topics beginning with the “Clark T. Sawin Historical Vignettes” led by Moderator Leonard Wartofsky, in which Lewis E. Braverman will speak on the History of the ITC; Shigenobu Nagataki will discuss the History of AOTA; Eduardo Pretell will present LATS and Regional Thyroid Highlights; and Wilmar Wiersinga will share his Thoughts about the History of the ETA.

Exploring ”TH Metabolism –Translational Physiology” will be session Chairs Anne van der Spek and Salvatore Benvenga, with a talk on Genetic and Functional Variation in Type 2 Deiodinase to be presented by Elizabeth A. McAninch; a presentation on Animal Models of Non-Thyroidal Illness by Emmely de Vries; and a discussion of “Metabolism in Human NTI” by Greet van den Berghe.

The Tuesday afternoon symposia at ITC will also include a session entitled “Fetal Programming in Maternal Thyroid Disease.” Joining Daniel Glinoer and Joanne Rovet are presenters Juan Bernal discussing Thyroid Hormone and Brain Development; Georg Brabant speaking on Brain Morphological Changes in Children Born to Mothers with Hypothyroidism; and Stine Linding Andersen focusing on Neurodevelopmental Disorders in Children Born to Mothers with Thyroid Dysfunction.

The symposium “Emerging Genes and Pathways in Thyroid Cancer” led by Chairs Sissy Jhiang and Keith Bible will include presentations on Molecular Genetics of Thyroid Tumor Progression by Paula Soares; Genetics of Radiation-Associated Thyroid Cancer by Horst Zitzelsberger; and Molecular Determinants of Signaling and Differentiation in Thyroid Cancer by Pilar Santisteban.

The ITC Program Organizing Committee (POC) has invited renowned international thyroid experts for every symposium and discussion/debate. The POC has designed this ITC to highlight and involve young investigators from around the world.  The American Thyroid Association (ATA) will continue to promote the E. Chester Ridgway Trainee Conference with a unique and focused track for trainees; participation includes accommodations and complimentary registration for a limited number of applicants who are first authors on accepted abstracts.  The four international thyroid associations combine their efforts to contribute to this one of a kind, state-of-the-science experience! Don’t miss this “top of the mark” collegial event.

Hosted by the ATA, the ITC will bring together the international community of thyroid researchers and clinicians to present and discuss the latest advances and controversies in thyroidology.  The ATA and its annual meetings are well known and well regarded by all those devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health.

###

The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis, and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,700 members from 43 countries around the world. Celebrating its 92^nd anniversary, the ATA delivers its mission — of being devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health — through several key endeavors: the publication of highly regarded professional journals, Thyroid, Clinical Thyroidology, and VideoEndocrinology; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease and thyroid cancer. The ATA promotes thyroid awareness and information through its online Clinical Thyroidology for the Public (distributed free of charge to over 11,000 patients and public subscribers) and extensive, authoritative explanations of thyroid disease and thyroid cancer in both English and Spanish. The ATA website serves as the clinical resource for patients and the public who look for reliable information on the Internet.  Every fifth year, the American Thyroid Association joins with the Latin American Thyroid Society, the European Thyroid Association, and the Asia and Oceania Thyroid Association to co-sponsor the International Thyroid Congress (ITC).  This year the ITC is hosted by the American Thyroid Association at the Walt Disney World Swan and Dolphin Resort.  More information about the 15^th ITC can be found at http://www.thyroid.org/itc2015/.

The post New Advances in Treating Thyroid Disease and Understanding Thyroid Function to be Highlighted at International Thyroid Congress appeared first on American Thyroid Association.

Featuring symposia, panel discussions and debates, and Plenary Lectures led by renowned endocrinology specialists, surgeons, and other healthcare professionals and experts in thyroidology from around the world, the 15^th International Thyroid Congress (ITC) will take place October 18-23, 2015 at the Walt Disney World Swan and Dolphin Resort in Lake Buena Vista, Florida. The ITC, held every five years, is a collaborative meeting of the four world thyroid associations: ATA (American Thyroid Association), Asia & Oceania Thyroid Association (AOTA), European Thyroid Association (ETA), and Latin American Thyroid Society (LATS).

On Monday, October 19, Day Two of ICT will feature a morning Plenary Lecture entitled “Advancing Individualized Medicine with Public-Private Partnerships,” delivered by Bill Chin, with an  introduction by Robert Smallridge. Highlights of the Monday afternoon program include the ATA Memorial for John B. Stanbury and presentation of the Stanbury Pathophysiology Medal to Sheue-yann Cheng. The winner of the 2015 ATA Van Meter Award will also be announced, and the recipient will deliver the Van Meter Award Lecture.

A series of lively Discussions/Debates on Monday will focus on either clinical topics or basic/translational areas of research. Announced topics and participants for the Clinical Discussions/Debates include: “A Case-based Discussion of International Hypothyroidism Guidelines” with Jacqueline Jonklaas, Glaucia Mazeto and Salman Razvi; “Targeted Therapy for Thyroid Cancer: When and What? with Steven I. Sherman and Johannes W.A. Smit; “Unusual Thyroid Function Tests” with Mark Vanderpump (moderator), Inge Pedersen, Brian W. Kim, Shu Wang and Helton Estrela Ramos; “Management of Thyroid Storm” with Henry B. Burch and Tetsurou Satoh; and “Is There a Role for Long-Term Anti-Thyroid Drug Therapy?” with Stig Andersen and Douglas S. Ross.

Monday’s Basic/Translational Discussions/Debates will feature the following topics and participants: “TSHR Activation and Its Impact on Body Composition and Graves’ Orbitopathy” with Marian Ludgate and Lei Zhang; “Oxidative Stress on Thyrocytes” with Denise Pires de Carvalho and Xavier De Deken; “Immunity and Thyroid Cancer: Prospects for Immune Therapy” with Carolin Lisa Zhang and Mabel Ryder; “Interactions Between Hypothalamic Pituitary Thyroid Axis and Other Pituitary Dysfunction” with Ulla Feldt-Rasmussen and Salvatore Benvenga; and “Vertebrate Models for Study of TH Action” with Luca Persani  and Yun-Bo Shi.

Symposiums on a range of hot topics chaired by world experts in their fields and featuring leading researchers and clinicians invited to share their knowledge and experiences will take place throughout the day on Monday. Beginning with the Early Riser Symposium, Chairs Ana O. Hoff and Laura Fugazzola have organized a session on “New Modalities in the Treatment of Medullary Thyroid Cancer (MTC)” featuring Rui M.B. Maciel speaking on Molecular Mechanisms of MTC; Rossella Elisei on Targeted Therapeutic Agents for MTC; Barbara Jarzab on Management of Side Effects of Long-Term Tyrosine Kinase Inhibitor Treatment; and Samuel Wells providing an Update on MTC Guidelines.

Morning symposia on Monday at ITC will include four parallel sessions. In the symposium called “Nontraditional TSHR Signaling” Chairs Basil Rapoport and Syed Morshed will highlight the work of presenters Terry F. Davies on Selective TSHR Signaling by TSHR Antibodies; Susanne E. Neumann on TSHR-Arrestin-1 Mediated Pathways; and Terry J. Smith on TSHR-IGF-1 Interactions.

“TR Alpha Mutations – Bench to Bedside,” led by Chairs V. Krishna Chatterjee and Marcel Meima, will include the following topics: Animal Models presented by Sheue-yann Cheng; Treatment of Animal Models by J.H. Duncan Bassett; Human Mutations by Carla Moran; and Treatment of Patients by Robin Peeters.

The symposium entitled “New Concepts in the Management of Thyroid Nodules“ organized by Chairs Stephanie Fish and Finn Bennedbaek, will feature presentations by Shuhang Xu on Epidemiology of Benign Thyroid Nodules; Arthur B. Schneider on Who Should Be Screened for Thyroid Nodules?; and Susan J. Mandel on Follow-Up of Benign Nodules?

Chairs Edna Kimura and Ileana Gabriela de Rubio will lead the symposium on “Thyroid Cancer – Translating Basic Science Discoveries to the Clinic,” with presenters James A. Fagin speaking on Redifferentiation of RAI-Refractory Thyroid Cancer; Yuri Nikiforov on Somatic Mutations Analysis for Molecular Diagnosis; and Sophie Leboulleux on Targeted Therapy.

ITC’s Monday afternoon program will feature another set of four fascinating symposia including “Clinical Utility of Anti-Thyroid Antibody Measurements” with Chairs Patricia de Fatima dos Santos Teixeira and Yuji Hiromatsu and presentations by Alex Stagnaro-Green on Pregnancy; Mario Rotondi on Hashimoto’s Thyroiditis; and Eijun Nishihara on Graves’ Disease.

Exploring the topic “TH Transport” will be session Chairs Ulrich Schweizer and Grant Anderson, with focused presentations on Animal Models of TH Transporter Disease by Heike Heuer; Therapeutic Studies Using Animal Models by Alexandra Dumitrescu; Human TH Transporter Mutations by Theo J. Visser; and Clinical Trials in Allan Herndon Dudley Syndrome by Edward Visser.

The Monday afternoon symposia at ITC will include a session entitled “T4/T3 Combination Therapy for Hypothyroidism.” Joining Chairs Elizabeth Mcaninch and Birte Nygaard are presenters Colin M. Dayan discussing Do Patients Prefer T4/T3 Therapy, and Why?; Francesco Celi speaking on What is the Mechanism for Enhanced Weight Loss with T3?; and Anne R. Cappola focusing on Risks/Safety of Combination Therapy. The symposium “Prognostic Assessment of Thyroid Cancer” led by Chairs Mario Vaisman and Duncan Topliss targets three key areas: Functional Imaging, to be discussed by Byeong-Cheol Ahn; Clinical Risk Stratification, presented by Furio Pacini; and Real Time Prognostication, explored by R. Michael Tuttle.

The ITC Program Organizing Committee (POC) has invited renowned international thyroid experts for every symposium and discussion/debate. The POC has designed this ITC to highlight and involve young investigators from around the world.  The American Thyroid Association (ATA) will continue to promote the E. Chester Ridgway Trainee Conference with a unique and focused track for trainees; participation includes accommodations and complimentary registration for a limited number of applicants who are first authors on accepted abstracts.  The four international thyroid associations combine their efforts to contribute to this one of a kind, state-of-the-science experience! Don’t miss this “top of the mark” collegial event.

Hosted by the ATA, the ITC will bring together the international community of thyroid researchers and clinicians to present and discuss the latest advances and controversies in thyroidology.  The ATA and its annual meetings are well known and well regarded by all those devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health.

###

The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis, and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,700 members from 43 countries around the world. Celebrating its 92^nd anniversary, the ATA delivers its mission — of being devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health — through several key endeavors: the publication of highly regarded professional journals, Thyroid, Clinical Thyroidology, and VideoEndocrinology; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease and thyroid cancer. The ATA promotes thyroid awareness and information through its online Clinical Thyroidology for the Public (distributed free of charge to over 11,000 patients and public subscribers) and extensive, authoritative explanations of thyroid disease and thyroid cancer in both English and Spanish. The ATA website serves as the clinical resource for patients and the public who look for reliable information on the Internet.  Every fifth year, the American Thyroid Association joins with the Latin American Thyroid Society, the European Thyroid Association, and the Asia and Oceania Thyroid Association to co-sponsor the International Thyroid Congress (ITC).  This year the ITC is hosted by the American Thyroid Association at the Walt Disney World Swan and Dolphin Resort.  More information about the 15^th ITC can be found at http://www.thyroid.org/itc2015/.

The post World Renowned Thyroid Experts Present New Research and Latest Treatment Practices at International Thyroid Congress appeared first on American Thyroid Association.

Prior to the ITC Opening Session and Welcome Ceremony on the evening of Day One of the ITC meeting, Sunday, October 18, The ATA sponsored the E. Chester Ridgway Trainee Conference. A day-long Endocrine Neck Advanced Ultrasound Course with Practicum was Chaired by Susan Mandel and Kevin Brumund.  Elizabeth Pearce Chaired the Iodine Global Network Satellite Program.

On Sunday evening, the Opening Session, entitled "Progress in Thyroid Research — Highlights from the Last Decade," and Chaired by Rebecca Bahn, will include presentations by Sandra M. McLachlan on Autoimmunity; Martin Schlumberger on Thyroid Cancer; Douglas Forrest on Thyroid Hormone Action; and David S. Cooper on Clinical Thyroidology.

Following three full days of Plenary and Award Lecture, timely and relevant discussions and debates on basic/translational and clinical topics; symposia on a broad range of areas related to thyroid disease, thyroid function, and new treatment strategies for thyroid cancer, for example and oral abstract and poster sessions, the final conference day, Friday, October 23, begins with a Plenary Lecture called "Progress in Surgical Management of Neoplasia and Hyperthyroidism" presented by Sally E. Carty, with an introduction by Electron Kebebew. Following the lecture will be a session of the Thyroid Cancer Tumor Board led by Moderator Bryan R. Haugen, with participants Jen Der Lin, Endocrinology; Kate Newbold, Medical Oncology, and Thomas Giordano, Molecular Biology.           

The ITC Program Organizing Committee (POC) has invited renowned international thyroid experts for every symposium and discussion/debate. The POC has designed this ITC to highlight and involve young investigators from around the world.  The American Thyroid Association (ATA) will continue to promote the E. Chester Ridgway Trainee Conference with a unique and focused track for trainees; participation includes accommodations and complimentary registration for a limited number of applicants who are first authors on accepted abstracts.  The four international thyroid associations combine their efforts to contribute to this one of a kind, state-of-the-science experience! Don’t miss this “top of the mark” collegial event.

Hosted by the ATA, the ITC will bring together the international community of thyroid researchers and clinicians to present and discuss the latest advances and controversies in thyroidology.  The ATA and its annual meetings are well known and well regarded by all those devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health.

###

The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis, and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,700 members from 43 countries around the world. Celebrating its 92^nd anniversary, the ATA delivers its mission — of being devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health — through several key endeavors: the publication of highly regarded professional journals, Thyroid, Clinical Thyroidology, and VideoEndocrinology; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease and thyroid cancer. The ATA promotes thyroid awareness and information through its online Clinical Thyroidology for the Public (distributed free of charge to over 11,000 patients and public subscribers) and extensive, authoritative explanations of thyroid disease and thyroid cancer in both English and Spanish. The ATA website serves as the clinical resource for patients and the public who look for reliable information on the Internet.  Every fifth year, the American Thyroid Association joins with the Latin American Thyroid Society, the European Thyroid Association, and the Asia and Oceania Thyroid Association to co-sponsor the International Thyroid Congress (ITC).  This year the ITC is hosted by the American Thyroid Association at the Walt Disney World Swan and Dolphin Resort.  More information about the 15^th ITC can be found at http://www.thyroid.org/itc2015/.

The post 15th International Thyroid Congress to Highlight Latest Advances in Research and Clinical Management of Thyroid Disease appeared first on American Thyroid Association.

Bite Me Cancer is the newest member of the ATA Alliance for Patient Education and ThyCa is a founding member.

2014 ATA Research Grants
Tatiana de Lourdes Fonseca, PhD – Rush University Medical Center, Chicago, Illinois
What is the Role of Type II Deiodinase (D2)-Mediated T3 Production in Liver and its Repercussion to Energy Expenditure?
Bio

Leo Kim, MD, PhD – Massachusetts Eye and Ear Infirmary, Boston, Massachusetts   Animal Models of Acute and Chronic Thyroid Eye Disease
Bio

Peter Taylor MB, ChB – Cardiff University, United Kingdom
The Impact of Maternal and Offspring Genetic Variants on Phenotypic Outcomes in the Controlled Antenatal Thyroid Screening Study (CATS).
Bio

W. Edward Visser, MD – Erasmus University Medical Center, Netherlands
Thyroid Hormone and Aging
Bio

2014 ATA ThyCa Grants
Elizabeth Grubbs, MD – The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Fusion Oncogenes as Drivers of Medullary Thyroid Cancer
Bio

Jason Prescott, MD, PhD – Johns Hopkins School of Medicine, Baltimore, Maryland
Development of a High Throughput in vivo Screening System for Small Molecule Activators of Thyroid Differentiation: Identification and Targeting of New Molecular Pathways Involved Thyroid Cancer Progression
Bio

Brian Untch, MD – Memorial Sloan-Kettering Cancer Center, New York, New York
Mechanisms of Response and Resistance to Farnesyltransferase Inhibition in HRAS-driven Thyroid Tumors
Bio

2014 ATA Bite Me Cancer Grant
Ramona Dadu, MD – The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Immune Markers in Medullary Thyroid Cancer (MTC) and Their Clinical Significance
Bio

2014 Second Year Grant Awardees:

ATA Research Grants
Jennifer Morrison, MD, PhD – University of Colorado – Denver, Colorado
TXNIP as a Regulator of Thyroid Cancer Aggressiveness
Bio

Joao Pedro Saar Werneck de Castro, PhD – University of Miami, Coral Gables, Florida
What is the Role Played by D2-mediated T3 Production in Skeletal Muscle?
Bio

Kevin Phillips, PhD – The Methodist Hospital Research Institute, Houston, Texas
The Contribution of Cyp7a1 to the Cholesterol Lowering Actions of TR Agonists
Bio
ATA ThyCa Grants – Medullary Thyroid Cancer
Nicole Chau, MD – Harvard Medical School, Boston, Massachusetts
Overcoming Resistance to RET inhibitors in Medullary Thyroid Cancer
Bio
ATA ThyCa Grants – Thyroid Cancer
Brittany Bohinc, MD – Duke University Hospital, Durham, North Carolina
Overexpression of LGR4 and LGR5 in Human Thyroid Cancer Promotes Wnt/β-Catenin Signaling and is Associated with Tumor Aggressiveness
Bio
Jaroslaw Jendrzejewski, MD – Ohio State University, Columbus, Ohio
Analysis of locus 14q13.3 in search of mutations predisposing to Papillary Thyroid Carcinoma (PTC)
Bio
###

The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis and treatment of thyroid disorders and thyroid cancer. ATA is an international individual membership organization with over 1,400 members from 43 countries around the world.

Celebrating its 91^st  anniversary, ATA delivers its mission through several key endeavors: the publication of highly regarded monthly journals, THYROID, Clinical Thyroidology, VideoEndocrinology and Clinical Thyroidology for the Public; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease.

More information about ATA is found at www.thyroid.org.

The post The American Thyroid Association recognizes research grant collaboration of patient support groups: Bite Me Cancer and ThyCa: Thyroid Cancer Survivors’ Association, Inc. appeared first on American Thyroid Association.

The post 38th ETA Annual Meeting appeared first on American Thyroid Association.